ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
28 02 2020
Historique:
received: 01 09 2019
accepted: 13 12 2019
pubmed: 20 12 2019
medline: 4 9 2020
entrez: 20 12 2019
Statut: epublish

Résumé

Cells sense pathogen-derived double-stranded RNA (dsRNA) as nonself. To avoid autoimmune activation by self dsRNA, cells utilize A-to-I editing by adenosine deaminase acting on RNA 1 (ADAR1) to disrupt dsRNA structures. Considering that viruses have evolved to exploit host machinery, A-to-I editing could benefit innate immune evasion by viruses. Borna disease virus (BoDV), a nuclear-replicating RNA virus, may require escape from nonself RNA-sensing and immune responses to establish persistent infection in the nucleus; however, the strategy by which BoDV evades nonself recognition is unclear. Here, we evaluated the involvement of ADARs in BoDV infection. The infection efficiency of BoDV was markedly decreased in both ADAR1 and ADAR2 knockdown cells at the early phase of infection. Microarray analysis using ADAR2 knockdown cells revealed that ADAR2 reduces immune responses even in the absence of infection. Knockdown of ADAR2 but not ADAR1 significantly reduced the spread and titer of BoDV in infected cells. Furthermore, ADAR2 knockout decreased the infection efficiency of BoDV, and overexpression of ADAR2 rescued the reduced infectivity in ADAR2 knockdown cells. However, the growth of influenza A virus, which causes acute infection in the nucleus, was not affected by ADAR2 knockdown. Moreover, ADAR2 bound to BoDV genomic RNA and induced A-to-G mutations in the genomes of persistently infected cells. We finally demonstrated that BoDV produced in ADAR2 knockdown cells induces stronger innate immune responses than those produced in wild-type cells. Taken together, our results suggest that BoDV utilizes ADAR2 to edit its genome to appear as "self" RNA in order to maintain persistent infection in the nucleus.

Identifiants

pubmed: 31852792
pii: JVI.01513-19
doi: 10.1128/JVI.01513-19
pmc: PMC7158724
pii:
doi:

Substances chimiques

RNA, Viral 0
RNA-Binding Proteins 0
ADARB1 protein, human EC 3.5.4.4
Adenosine Deaminase EC 3.5.4.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Nucleic Acids Res. 2009 Sep;37(17):5848-58
pubmed: 19651874
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15118-23
pubmed: 12399548
J Virol. 2015 Sep;89(18):9383-92
pubmed: 26136565
J Biol Chem. 2007 Jun 1;282(22):16054-61
pubmed: 17428802
J Virol. 2015 Jun;89(11):6067-79
pubmed: 25810557
Nat Immunol. 2006 Feb;7(2):131-7
pubmed: 16424890
Annu Rev Genet. 2017 Nov 27;51:241-263
pubmed: 28853921
Cell. 1987 Feb 27;48(4):607-13
pubmed: 2434241
J Virol. 2011 Aug;85(16):8338-47
pubmed: 21632755
Proc Natl Acad Sci U S A. 1989 Apr;86(8):2647-51
pubmed: 2704740
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7206-11
pubmed: 21482759
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12174-9
pubmed: 20566853
Virus Res. 1985 Feb;2(1):29-33
pubmed: 3920840
Viruses. 2015 May 22;7(5):2668-82
pubmed: 26008706
J Virol. 2005 May;79(10):6291-8
pubmed: 15858013
Biochemistry. 2000 Oct 24;39(42):12875-84
pubmed: 11041852
Cell. 1991 Oct 4;67(1):11-9
pubmed: 1717158
Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):331-6
pubmed: 21173229
PLoS Pathog. 2013;9(7):e1003440
pubmed: 23853584
Nature. 1996 Feb 1;379(6564):460-4
pubmed: 8559253
Virol J. 2017 Jul 11;14(1):126
pubmed: 28693611
J Gen Virol. 1985 Nov;66 ( Pt 11):2479-84
pubmed: 3932595
J Neuroimmunol. 2003 Apr;137(1-2):67-78
pubmed: 12667649
Rev Sci Tech. 2000 Apr;19(1):259-88
pubmed: 11189720
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Nature. 1986 Oct 9-15;323(6088):508-14
pubmed: 3762705
Cell Host Microbe. 2012 May 17;11(5):492-503
pubmed: 22607802
Cell. 1988 Oct 21;55(2):255-65
pubmed: 3167982
J Biol Chem. 2016 Mar 18;291(12):6158-68
pubmed: 26817845
J Virol. 2015 Aug;89(15):7735-47
pubmed: 25972541
Cell Host Microbe. 2012 Jun 14;11(6):607-16
pubmed: 22704621
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11457-61
pubmed: 7972084
PLoS Biol. 2018 Nov 29;16(11):e2006577
pubmed: 30496178
EMBO J. 1991 Nov;10(11):3523-32
pubmed: 1915306
Cell. 2001 Aug 24;106(4):465-75
pubmed: 11525732
FEBS Lett. 2017 Sep;591(18):2890-2904
pubmed: 28833069
Brain Pathol. 1995 Jul;5(3):223-30
pubmed: 8520721
Cell. 1993 Dec 31;75(7):1361-70
pubmed: 8269514
Science. 2009 May 29;324(5931):1210-3
pubmed: 19478186
Science. 2007 Mar 2;315(5816):1274-8
pubmed: 17332413
Microbes Infect. 2002 Apr;4(4):491-500
pubmed: 11932200
J Virol. 2011 Mar;85(5):2458-62
pubmed: 21159878
Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11486-9
pubmed: 1454837
EMBO J. 1998 Feb 16;17(4):1120-7
pubmed: 9463389
Cell. 1988 Dec 23;55(6):1089-98
pubmed: 3203381
Mol Cell Biol. 1995 Oct;15(10):5376-88
pubmed: 7565688
Nature. 2017 Oct 11;550(7675):249-254
pubmed: 29022589
J Virol. 1992 Feb;66(2):992-8
pubmed: 1731117
Science. 2006 Nov 10;314(5801):997-1001
pubmed: 17038589
Nucleic Acids Res. 2017 Apr 20;45(7):4189-4201
pubmed: 28053121
Elife. 2017 Mar 31;6:
pubmed: 28362255
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Nature. 1997 May 15;387(6630):303-8
pubmed: 9153397
Nucleic Acids Res. 2004 Apr 15;32(7):2113-22
pubmed: 15087490
PLoS One. 2014 Oct 01;9(10):e108476
pubmed: 25272020
Curr Issues Mol Biol. 2015;17:37-51
pubmed: 25502818
PLoS Pathog. 2015 Sep 25;11(9):e1005166
pubmed: 26407100
J Virol. 2014 Jan;88(1):456-68
pubmed: 24155404
Nature. 1999 May 6;399(6731):75-80
pubmed: 10331393
PLoS One. 2008 Apr 30;3(4):e2032
pubmed: 18446221
Prog Med Virol. 1988;35:107-51
pubmed: 3051132
Microbiol Immunol. 2017 Sep;61(9):380-386
pubmed: 28776750
Nat Commun. 2017 Aug 29;8(1):375
pubmed: 28851882
J Biol Chem. 1995 Jul 21;270(29):17098-105
pubmed: 7615504
Science. 2015 Sep 4;349(6252):1115-20
pubmed: 26275108
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4362-6
pubmed: 8183914
RNA. 2000 May;6(5):755-67
pubmed: 10836796
Cell. 2018 Feb 8;172(4):811-824.e14
pubmed: 29395325
Virology. 2012 Jan 20;422(2):265-77
pubmed: 22104209
J Virol. 2002 Dec;76(23):12399-404
pubmed: 12414985
Virus Res. 2019 Apr 2;263:179-183
pubmed: 30769121
FEBS Lett. 2004 Aug 27;573(1-3):83-92
pubmed: 15327980
J Virol. 2009 Oct;83(19):10119-28
pubmed: 19605474
J Gen Virol. 2011 May;92(Pt 5):1228-1232
pubmed: 21289159
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3542-7
pubmed: 9108012

Auteurs

Mako Yanai (M)

Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.

Shohei Kojima (S)

Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.

Madoka Sakai (M)

Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.

Ryo Komorizono (R)

Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.

Keizo Tomonaga (K)

Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan tomonaga@infront.kyoto-u.ac.jp makino@infront.kyoto-u.ac.jp.
Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Department of Molecular Virology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Akiko Makino (A)

Laboratory of RNA Viruses, Department of Virus Research, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan tomonaga@infront.kyoto-u.ac.jp makino@infront.kyoto-u.ac.jp.
Laboratory of RNA Viruses, Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH